RBC Medical

RBC Medical RBC Medical partners with healthcare innovators to develop disruptive technologies, find innovative

SAFE, EFFECTIVE, INNOVATIVE -

RBC Medical allows sophisticated manufacturers of safe, effective, and innovative technologies access to patients and physicians, addressing critical health-related issues that affect millions each year. This technology focuses on mental health, pain, adherence to multi-medication heart therapy, toxicology screening, and reduced dependence on expensive pharmacologic

al products and services. The goal is to reduce medical costs and errors while improving patient outcomes, convenience and independence through physician education and service. RBC Medical partners with medical solution-based companies which help physicians address the out of office treatment and diagnosis referrals that increase patient costs and delay and prolong treatment. This aids physicians in improving patient outcomes within their practice setting, certainly a worthy goal for the physician and patient.

This is our partner, Dmitry. He's a professor of bioinformatics and computational biology at Worcester Polytechnic Insti...
04/24/2020

This is our partner, Dmitry. He's a professor of bioinformatics and computational biology at Worcester Polytechnic Institute in Worcester, Massachusetts, who specializes in the bioinformatics of complex disease, computational genomics, systems biology, and biomedical data analytics. He was the first to use the viral genome of the COVID-19 to reconstruct the 3D structure of its major viral proteins and their interactions with human proteins, in effect creating a structural genomics map of the coronavirus and making this data open and available to researchers everywhere. He's at the forefront of the world's research in finding a cure for CoVid-19, along with being wicked smart and extremely humble. And we are very proud.

Dmitry Korkin is a professor of bioinformatics and computational biology at Worcester Polytechnic Institute, where he specializes in bioinformatics of comple...

Hydroxychloroquine is definitely on the back burner until proven...and that remains very questionable.
04/24/2020

Hydroxychloroquine is definitely on the back burner until proven...and that remains very questionable.

After President Donald Trump touted the malaria drug hydroxychloroquine as a potential COVID-19 “game-changer," the FDA authorized it for emergency use. But now the drug regulator is warning about serious side effects.

Antibody testing has to be accurate to be helpful. A ton of carpet baggers have surfaced selling snake oil, so be carefu...
04/24/2020

Antibody testing has to be accurate to be helpful. A ton of carpet baggers have surfaced selling snake oil, so be careful.

The current state of antibody testing for COVID-19 is “a disaster,” said Roche CEO Severin Schwan, as a large number of potentially inaccurate tests enter the market fueled by sky-high demand.

Smart guy...and served as the liaison with the manufacturers the government is contracting, such as Moderna and J&J.
04/24/2020

Smart guy...and served as the liaison with the manufacturers the government is contracting, such as Moderna and J&J.

The U.S. agency leading efforts to develop a vaccine against COVID-19 has lost its leader. Rick Bright, a vaccine specialist, is moving to a new role in the National Institutes of Health (NIH) at a time when his former employer is scrambling to help biopharma make a COVID-19 prophylactic available.

Hydroxychloroquine takes another hit on alleged efficacy. Why again the controlled studies are critical.
04/24/2020

Hydroxychloroquine takes another hit on alleged efficacy. Why again the controlled studies are critical.

Antimalarial hydroxychloroquine has raked in support as a potential wonder drug to treat COVID-19, with even President Donald J. Trump touting it as a possible "game changer." But small-scale studies have been less than definitive on the drug's chances—and new data haven't cleared matters up much.

We need the controlled studies for remdesvir and the science because inconsistency is not helpful. This leaked study cam...
04/24/2020

We need the controlled studies for remdesvir and the science because inconsistency is not helpful. This leaked study came only a few days after another report from the University of Chicago, which was also leaked, detailed rapid recovery in fever and respiratory symptoms in some patients with COVID-19.

A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.

Have to be smart about it. Fauci is a national treasure and we're blessed to have him.
04/24/2020

Have to be smart about it. Fauci is a national treasure and we're blessed to have him.

As the U.S. economic toll from COVID-19 lockdowns continue to mount—with tens of millions out of work and businesses suffering—discussion has turned to re-opening the economy even as confirmed cases nationwide continue to climb.

Potentially encouraging, but "drawing any conclusions at this point is premature and scientifically unsound.” Still, the...
04/24/2020

Potentially encouraging, but "drawing any conclusions at this point is premature and scientifically unsound.” Still, there's hope. We have to have that.

The outcomes in patients at a Chicago hospital offer only a snapshot of remdesivir’s effectiveness, but are the first clinical data to surface to date.

After a late February meeting with 170 Biogen managers, many of whom became sick and helped to seed CoVid in Boston, Bio...
04/24/2020

After a late February meeting with 170 Biogen managers, many of whom became sick and helped to seed CoVid in Boston, Biogen employees are giving blood to try to help.

Early in the U.S. COVID-19 outbreak, Biogen’s February meeting in Boston played a central role in spreading the virus in Massachusetts and beyond. Now that many employees have recovered, they’re donating blood samples to a “biobank" to help researchers learn more about the virus.

The future is an at-home test for CoVid. We're working to do the same with a different technology but with the same end ...
04/24/2020

The future is an at-home test for CoVid. We're working to do the same with a different technology but with the same end goal. To help collaboratively.

Sanofi has begun working with California startup Luminostics to build an at-home test for COVID-19 that would use a sample reader powered by a user’s personal smartphone.

Address

429 S Keller Road, Ste 220
Orlando, FL
32810

Telephone

+14078382000

Website

Alerts

Be the first to know and let us send you an email when RBC Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category